6533b7d9fe1ef96bd126d557

RESEARCH PRODUCT

27. Differences in adjuvant chemotherapy administration for stage II colon cancer patients – a EURECCA international comparison

A.j. BreugomL. Van EyckenC.j.h. Van De VeldeLars PåhlmanLene Hjerrild IversenR. JanciauskieneEsther BastiaannetValery E.p.p. LemmensPetra G. BoelensAndrés Cervantes

subject

Oncologymedicine.medical_specialtyOncologybusiness.industryAdjuvant chemotherapyInternal medicinemedicineSurgeryGeneral MedicinebusinessAdministration (government)Stage ii colon cancerhttps://doi.org/10.1016/j.ejso.2014.08.024